Related Experiment Videos

[Some problems on the clinical phenotype of Machado-Joseph disease in relation between their ages at onset]

K Iwabuchi1, T Kogure, T Oda

  • 1Department of Neuropathology, Tokyo Institute of Psychiatry, Japan.

No to Shinkei = Brain and Nerve
|March 1, 1993
PubMed
Abstract

Insights

Machado-Joseph disease (MJD) phenotypes are linked to age at onset. Early onset MJD shows dystonia, while later onset presents with cerebellar ataxia and hypotonia.

Area of Science:

  • Neurology
  • Genetics
  • Pathology

Context:

  • Machado-Joseph disease (MJD), also known as spinocerebellar ataxia type 3 (SCA3), is an autosomal dominant neurodegenerative disorder.
  • Clinical presentation of MJD is heterogeneous, with varying ages of onset and symptom progression.

Purpose:

  • To investigate the relationship between the age of onset and the clinical and neuropathological phenotypes of Machado-Joseph disease.
  • To differentiate MJD subtypes based on clinico-pathological findings and age at onset.

Summary:

  • This study examined six patients from two families with MJD, correlating clinical features and neuropathological findings with age at onset.
  • Three distinct MJD phenotypes (Type 1, 2, and 3) were identified, primarily distinguished by initial symptoms and progression patterns related to age at onset.
  • Neuropathological findings, including degeneration in cerebellar and extrapyramidal systems, showed variations but did not always directly correlate with distinct clinical phenotypes.

Impact:

  • The findings suggest that age at onset is a critical factor in determining the clinical presentation and progression of Machado-Joseph disease.
  • This research aids in better understanding MJD heterogeneity and may inform diagnostic and therapeutic strategies.
  • Highlights the complex interplay between genotype, age, and phenotype in MJD.

Related Concept Videos